openPR Logo
Press release

Pigmented Villonodular Synovitis Drug Market Trends, Size, Competitive Analysis and Forecast 2021-2027

03-12-2022 11:10 AM CET | Health & Medicine

Press release from: Orion Market Research

The global pigmented villonodular synovitis drug market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Pigmented villonodular synovitis (PVNS) is a joint problem that affects the hip or knee and causes the lining of a joint to be swollen and grow which harms the bone around the joint. However, it can also occur in the shoulder, ankle, elbow, hand or foot. The major factor driving the growth of the market is the increasing number of in-patients in hospitals suffering from rare conditions and growing demand for advanced treatment across the globe. Moreover, the market is also growing due to the increasing incidence of PVNS disease. According to the National Center for Biotechnology Information (NCBI), PVNS is a rare disease with a prevalence of 9.2 patients out of a million population.

To Request a Sample of our Report on Pigmented Villonodular Synovitis Drug Market: https://www.omrglobal.com/request-sample/pigmented-villonodular-synovitis-drug-market

Some major players operating in the market include Bristol-Myers Squibb Co., Daiichi Sankyo Co., Ltd., and Novartis International AG, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in August 2019, Daiichi Sankyo Co., Ltd. announced the approval of TURALIO (pexidartinib) from the US Food and Drug Administration (FDA). It is the first and only treatment for symptomatic TGCT associated with severe morbidity or functional limitations and not amenable to improvement with surgery in adult patients. TGCT is also called pigmented villonodular synovitis (PVNS).

Market Coverage

• The market number available for - 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

Segment Covered-

· By Type

· By Application

Regions Covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

Competitive Landscape- Bristol-Myers Squibb Co., Daiichi Sankyo Company, Ltd., and Novartis International AG, among others.

(Get 15% Discount on Buying this Report)

A full Report of Pigmented Villonodular Synovitis Drug Market is Available @ https://www.omrglobal.com/industry-reports/pigmented-villonodular-synovitis-drug-market

Global Pigmented Villonodular Synovitis Drug Market Report by Segment

By Type

• Cabiralizumab

• Emactuzumab

• Mcs-110

• Nilotinib

• Others

By Application

• Clinic

• Hospital

• Homecare

Global Pigmented Villonodular Synovitis Drug Market Report by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pigmented Villonodular Synovitis Drug Market Trends, Size, Competitive Analysis and Forecast 2021-2027 here

News-ID: 2576926 • Views:

More Releases from Orion Market Research

AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2033
AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033. AI-Enabled Imaging Modalities Market Overview The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry Growths to 2033
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034. SNP genotyping Market Overview The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This

All 5 Releases


More Releases for Pigmented

Pigmented Villonodular Synovitis Drug Market Will Generate Record Revenue by 202 …
Pigmented villonodular synovitis drug market is anticipated to grow at a significant CAGR during the forecast period. Pigmented villonodular synovitis (PVNS) is a joint problem that affects the hip or knee and causes the lining of a joint to be swollen and grow which harms the bone around the joint. However, it can also occur in the shoulder, ankle, elbow, hand or foot. The major factor driving the growth of
Pigmented Lesion Treatment Market Top Players Revenue and Forecasts Research
"The Pigmented Lesion Treatment Market, Insights, Size, Growth, Challenges, Opportunities, Emerging Trends, and Geographic Regions, Forecast Period: to Pigmented Lesion Treatment Market" The emergence of new diseases, such as COVID-19 (novel coronavirus), is expected to propel the Pigmented Lesion Treatment Market growth during the forecast period. According to the World Health Organization (WHO), new diseases have been emerging at the unprecedented rate of one a year for the last two decades,
Pigmented Concrete Market - Forecast to 2026
As per the research conducted by GME, the Pigmented Concrete Market will grow with a CAGR value of around 7 percent over the forecast period. Browse TOC on “Global Pigmented Concrete Market - Forecast to 2026" https://www.globalmarketestimates.com/market-report/global-pigmented-concrete-market-2739 By Type (Stained, Dyed, Paint, Tinted Sealers, Integral Colour, Dry Shake Colour Hardener), By Application (Walls, Floors, Driveways & Sidewalks, Pool Decks, Patios), By End-Use (Residential, Non-Residential), By Region (North America, Asia Pacific, Europe,
Global Pigmented Paper Market Outlook (2014-2025)
The report on the global Pigmented Paper market has been prepared by experienced and knowledgeable market analysts and researchers. It is a phenomenal compilation of important studies that explore the competitive landscape, segmentation, geographical expansion, and revenue, production, and consumption growth of the global Pigmented Paper market. Players can use the accurate market facts and figures and statistical studies provided in the report to understand the current and future growth of the
Pigmented Paper Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Pigmented Paper Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Pigmented Paper players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Pigmented Paper with respect to individual growth
Pigmented Lesion Treatment Market – Worldwide Transformation Overview 2025 | L …
Global Pigmented Lesion Treatment Market: Overview The global market for pigmented lesion treatment is poised for a steady growth in the years ahead. Increasing prevalence of pigmented lesions is serving to drive the demand for its treatment worldwide. Pigmented lesions is a common skin condition among the geriatric population. Mostly visible on the face, it can be visible on other parts of the body as well. Extreme exposure to sun and aging